RANDOMIZED DOUBLE-BLIND-STUDY OF TEICOPLANIN (T) AND VANCOMYCIN (V) IN GRAM-POSITIVE BACTEREMIA (GPB) AND ENDOCARDITIS (GPE)

被引：0
|
作者：
GELFAND, MS
SIMMONS, BP
THRELKELD, MG
WINTERS, DB
GROGAN, JT
AMARSHI, N
ELSABAWY, MA
机构：
[1] METHODIST HOSP,MEMPHIS,TN 38104
[2] ST JOSEPH HOSP,MEMPHIS,TN
来源：
CLINICAL RESEARCH | 1991年 / 39卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A809 / A809
页数：1
相关论文
共 47 条
  • [1] A RANDOMIZED DOUBLE-BLIND TRIAL OF VANCOMYCIN VERSUS TEICOPLANIN FOR THE TREATMENT OF GRAM-POSITIVE BACTEREMIA IN PATIENTS WITH CANCER
    ROLSTON, KVI
    NGUYEN, H
    AMOS, G
    ELTING, L
    FAINSTEIN, V
    BODEY, GP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (02): : 350 - 355
  • [2] TEICOPLANIN IN THE TREATMENT OF GRAM-POSITIVE BACTEREMIA AND ENDOCARDITIS
    CRUCIANI, M
    CONCIA, E
    DIPERRI, G
    ADAMI, T
    NAVARRA, A
    FENDT, D
    DESTRO, G
    MARONE, P
    SOLBIATI, M
    BASSETTI, D
    [J]. CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 51 (05): : 704 - 714
  • [3] VANCOMYCIN VERSUS TEICOPLANIN FOR THE TREATMENT OF GRAM-POSITIVE BACTEREMIA IN PATIENTS WITH CANCER - REPLY
    ROLSTON, KVI
    ELTING, LS
    BODEY, GP
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (05): : 1344 - 1345
  • [4] Linezolid versus teicoplanin in the treatment of Gram-positive infections in the critically ill: a randomized, double-blind, multicentre study
    Cepeda, JA
    Whitehouse, T
    Cooper, B
    Hails, J
    Jones, K
    Kwaku, F
    Taylor, L
    Hayman, S
    Shaw, S
    Kibbler, C
    Shulman, R
    Singer, M
    Wilson, APR
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (02) : 345 - 355
  • [5] RANDOMIZED STUDY OF VANCOMYCIN VERSUS TEICOPLANIN FOR THE TREATMENT OF GRAM-POSITIVE BACTERIAL-INFECTIONS IN IMMUNOCOMPROMISED HOSTS
    VANDERAUWERA, P
    AOUN, M
    MEUNIER, F
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1991, 35 (03) : 451 - 457
  • [6] Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and Gram-positive bacteremia
    Sidi, V
    Roilides, E
    Bibashi, E
    Gompakis, N
    Tsakiri, A
    Koliouskas, D
    [J]. JOURNAL OF CHEMOTHERAPY, 2000, 12 (04) : 326 - 331
  • [7] Clinical relevance of a European collaborative study on comparative susceptibility of Gram-positive clinical isolates to teicoplanin and vancomycin
    Grüneberg, RN
    Hryniewicz, W
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1998, 10 (04) : 271 - 277
  • [8] PHARMACOKINETICS AND BACTERICIDAL RATES OF DAPTOMYCIN AND VANCOMYCIN IN INTRAVENOUS DRUG-ABUSERS BEING TREATED FOR GRAM-POSITIVE ENDOCARDITIS AND BACTEREMIA
    RYBAK, MJ
    BAILEY, EM
    LAMP, KC
    KAATZ, GW
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (05) : 1109 - 1114
  • [9] Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer
    Safdar, A
    Rolston, KVI
    [J]. CANCER, 2006, 106 (08) : 1815 - 1820
  • [10] Addition of teicoplanin or vancomycin for the treatment of documented bacteremia due to gram-positive cocci in neutropenic patients with hematological malignancies: Microbiological, clinical and economic evaluation
    D'Antonio, D
    Staniscia, T
    Piccolomini, R
    Fioritoni, G
    Rotolo, S
    Parruti, G
    Di Bonaventura, G
    Manna, A
    Savini, V
    Fiorilli, MP
    Di Giovanni, P
    Francione, A
    Schioppa, F
    Romano, F
    [J]. CHEMOTHERAPY, 2004, 50 (02) : 81 - 87
12345